Location: 455B Portage Ave, Palo Alto, California, United States United States
Founded in: 2017
Stage: Pre-launch
Number of employees: 1-5
Funding history:
- Date: 06/2017, Accelerator/Incubator: $120 k
Short URL:

Spect Inc.

Palo Alto, California, United States United States
  • About
Company description

Vision Disease cause innumerable cases of preventable blindness globally - 415 million diabetic patients worldwide are susceptible to Diabetic Retinopathy (DR), Glaucoma, and more. Current screening protocols for vision disease require ophthalmologists to manually diagnose patients through visual assessment of the fundus. Given the large number of diabetes patients in various communities, this process is expensive, inefficient, and an undue burden on eye clinics. 

Our goal is to leverage cutting edge technology to catch Ophthalmic disease early and prevent expensive, late-stage treatment. We build software that screens for all vision complications - through a single retinal image.

  • Ankur Gupta
    Ankur Gupta | Founder
    B.S, M.S., and Biodesign at Stanford; M.D. at UT Southwestern (taught Biodesign for 5 years). Biotech + VC experience. Ophthalmology at the National Eye Institute, UChicago, and WashU. Most recently co-founded Spect after graduating Y-Combinator.
  • Theodore Leng
    Theodore Leng | Founder
Investor Deafult Image
Y Combinator - Unconfirmed